Company Filing History:
Years Active: 2003-2014
Title: Innovations by Beverley Jane Carr: Pioneering Treatments for Obesity
Introduction
Beverley Jane Carr is an accomplished inventor based in Royston, GB, known for her impactful contributions to the field of medicine, particularly in the treatment of obesity. With a portfolio that includes six patents, Beverley's work reflects her commitment to innovative solutions that address health challenges.
Latest Patents
Beverley's latest patents focus on 2-oxy-benzoxazinone derivatives for the treatment of obesity. These compounds, defined by a specific formula, serve to inhibit enzymes responsible for catalyzing the hydrolysis of ester functionalities. This groundbreaking invention has potential applications not only in inhibiting unwanted enzymes in various products and processes but also in the development of pharmaceutical compositions for treating obesity and related conditions. The innovative formula includes a 6-membered aromatic or heteroaromatic ring, with the compound structure allowing for various alkyl, alkenyl, and aromatic groups, which enhances its efficacy.
Career Highlights
Throughout her career, Beverley has collaborated with notable companies, including Norgine BV and Alizyme Therapeutics Limited. Her work within these organizations has been pivotal in advancing research and development in therapeutic innovations, particularly those aimed at combating obesity.
Collaborations
Beverley has collaborated with esteemed colleagues, including Harold Francis Hodson and Robert Downham. These partnerships have facilitated the exchange of ideas and knowledge, significantly advancing her research initiatives and innovations.
Conclusion
Beverley Jane Carr exemplifies the spirit of innovation in the medical field, with her contributions paving the way for effective treatments of obesity. Her patents not only highlight her inventiveness but also underscore the importance of collaboration in achieving significant advancements in healthcare.